Nestmedic, an innovative telemedicine company and the creator of Pregnabit – a mobile teleCTG system, announces changes in the Company’s Management Board: Jacek Gnich is now the President of the Board and dr n. med. Patrycja Wizińska-Socha, the Company’s former CEO, is a Board member. At the same time, Konrad Kowalczuk has resigned from his position of a Member of the Management Board. The Company announces the development of a new strategy for the system development and commercialisation.
Jacek Gnich, the new CEO of Nestmedic, has extensive experience in commercialisation of innovative products. He is professionally involved with Scanderia Venture, where he has been the President of the Management Board since 2017. He also served as the President of the Management Board at Infoscan S.A., where he increased the scope of corporate operations in Poland and in foreign markets, and attracted new investors. Previously, he was, among others, financial director at Kino Polska TV sp. z o.o. and a member of the Supervisory Board of Kansas Semiconductor LLC based in the US. He has extensive knowledge of finance; he is the author of a guide for SMEs: The Accounting Act: Commentary, published by the Polish Agency for Enterprise Development (PARP).
– I can see a great potential in the Pregnabit system, both in Poland and on international markets. I strongly believe in this product, and I am very happy that I will be able to develop it together with a team of leading professionals who have worked on it before. I hope that my professional experience and knowledge in the field of product commercialisation will bring some tangible benefits for Nestmedic. One of my first tasks as the CEO will be to update the Company’s action plan for the device sales and technological development. We will announce the details of new initiatives in Q1 2020, comments Jacek Gnich, CEO of Nestmedic.
As CEO, Jacek Gnich succeeded dr n. med. Patrycja Wizińska-Socha, a co-founder of Nestmedic, who has created and marketed the Pregnabit system, i.e. a comprehensive telemedical solution for fetal well-being examination. She is a pharmaceutical biotechnologist by education, and a graduate of Wrocław University of Science and Technology. Taking up the position of a Member of the Management Board will allow her to focus on further development of Pregnabit.
– Following the changes in the Management Board, I will concentrate largely on work related to medical aspects of the device and further development of the system. I am convinced that the new composition of the Management Board will effectively accelerate our efforts related to commercialisation of the Pregnabit system and boost the Company’s technological potential, adds Patrycja Wizińska-Socha, Member of Nestmedic’s Management Board.
